New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

Palatin Technologies, Inc. December 31, 2010 Quarter Results; Teleconference and Webcast to be Held on February 24, 2011

CRANBURY, N.J., Feb. 18, 2011 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) will host a conference call and webcast on February 24, 2011 at 11:00 a.m. Eastern Time to discuss its quarter ended December 31, 2010 financial results and plans for its programs under development.  

Schedule for the Financial Results Press Release, Conference Call / Webcast

  • Q2 Fiscal Year 2011 Conference Call-Live

Domestic Dial-In Number

International Dial-In Number

Pass code

2/24/2011 at 11:00 a.m. ET


1-888-254-2801

1-913-981-4905

2873560



  • Q2 Fiscal Year 2011 Conference Call-Replay

Domestic Dial-In Number

International Dial-In Number

Pass code

2/24-3/3/2011


1-888-203-1112

1-719-457-0820

2873560



  • Webcast Live and Replay Access

http://www.palatin.com

The webcast and replay can be accessed by logging on to the “Investor/Media Center-Webcasts” section of Palatin’s website at http://www.palatin.com

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin Technologies’ website at www.palatin.com.

SOURCE Palatin Technologies, Inc.

Scroll to Top